e-Clinical trials technology yet to take off in a big way:Report

摘要

There has been a paradigm shift in the drug discovery industry in recent years,with computing power and informatics becoming an integral part of the discovery and development process.With life-sciences and pharmaceutical companies showing a definite inclination towards electronic technologies and investing substantial amounts in transitioningfrom paper-based to electronic processes,revenues in the eClinical trials (eCT) market are expected to increase from approximately US210-mn in 2004 to US357.4-mn in 2011,a Frost & Sullivan study reveals.